High rates of resistance to piperacillin/tazobactam among Escherichia coli and Klebsiella pneumoniae strains isolated in a Greek hospital

Diagnostic Microbiology and Infectious Disease

Volumn 29, Issue 1, 1997, Pages 39-41

  Tsakris, Athanassios ^a   Douboyas, John ^b   Tzouvelekis, Leonidas S ^c  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b AHEPA UNIVERSITY HOSPITAL   (Greece)

^c HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFIXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; MEZLOCILLIN; PIPERACILLIN; TAZOBACTAM;

CONTROLLED STUDY; ESCHERICHIA COLI; GREECE; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SHORT SURVEY; UNIVERSITY HOSPITAL;

EID: 0030780696     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(97)00081-3     Document Type: Article

References (16)

1. Chen HY, Bonfiglio G, Alien M, Piper D, Edwardson T, McVey D, Livermore DM (1993) Multicenter survey of the comparative in vitro activity of piperacillin/tazobactam against bacteria from hospitalized patients in the British Isles. J Antimicrob Chemother 32:247-266.
2. French GL, Shannon KP, Simmons N (1996) Hospital outbreak of Klebsiella pneumoniae resistant to broadspectrum cephalosporins and β-lactam-β-lactamase inhibitor combinations by hyperproduction of SHV-5 βlactamase. J Clin Microbiol 34:358-363.
3. Gazouli M, Tzouvelekis LS, Prinarakis E, Miriagou V, Tzelepi E (1996) Transferable cefoxitin-resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group-1 β-lactamase (LAT-2). Antimicrob Agents Chemother 40:1736-1740.
4. Henquell C, Chanal C, Sirot D, Labia R, Sirot J (1995) Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM βlactamases from clinical isolates of Escherichia coli. Antimicrob Agents Chemother 39:427-430.
5. Jarlier V, Nicolas MH, Fournier G, Philippon A (1988) Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev Infect Dis 10:867-878.
6. Jett BD, Ritchie DJ, Reichley R, Bailey TC, Sahm DF (1995) In vitro activities of various β-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins. Antimicrob Agents Chemother 39:1187-1190.
7. Jones RN, Pfaller MA, Fuchs PC, Aldridge KE, Allen SD, Gerlach EH (1989) Piperacillin/tazobactam (YTR 830) combination comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains. Diagn Microbiol Infect Dis 12:489-494.
8. Livermore DM (1995) β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8:557-584.
9. Legakis NJ, Tsakris A (1992) Antibiotic resistance mechanisms in Gram-negative bacteria: the Greek experience. Int J Exp Clin Chemother 5:83-91.
10. Legakis NJ, Tzouvelekis LS, Tsakris A, Legakis JN, Vatopoulos AC (1993) On the incidence of antibiotic resistance among aerobic Gram-negative rods isolated in Greek hospitals. J Hosp Infect 24:233-237.
11. Martinez-Martinez L, Hernandez-Alles S, Alberti S, Tomas JM, Benedi VJ, Jacoby JA (1996) In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expandedspectrum cephalosporins. Antimicrob Agents Chemother 40:342-348.
12. Marshall SA, Aldridge KE, Allen SD, Fuchs PC, Gerlach EH, Jones RN (1995) Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers. A reevaluation after five years. Diagn Microbiol Infect Dis 21:153-168.
13. National Committee for Clinical Laboratory Standards (NCCLS) (1992) Performance Standards for Antimicrobial Disc Susceptibility Tests. Approved Standard M2-A2. Villanova, PA: NCCLS.
14. National Committee for Clinical Laboratory Standards (NCCLS) (1993) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 3rd Edition; Approved Standard M7-A3. Villanova, PA: NCCLS.
15. Stapleton P, Wu P, King A, Shannon K, French G, Phillips I (1995) Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob Agents Chemother 39:2478-2483.
16. Sutherland R (1995) β-lactam/β-lactamase inhibitor combinations: Development, antibacterial activity and clinical applications. Infection 23:191-200.